Receipt of "Attestation of Inspection" from EDQM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Smruthi Organics Ltd has received an 'Attestation of Inspection' from the EDQM (European Directorate for the Quality of Medicines & HealthCare), as disclosed via BSE. EDQM attestation is a regulatory clearance related to GMP (Good Manufacturing Practice) compliance for pharmaceutical manufacturing sites supplying the European market. The full filing details — including which facility was inspected and the scope of products covered — are not available in the source document provided. This typically follows a successful European regulatory inspection of the company's manufacturing facility.
EDQM attestation is a positive regulatory milestone that supports the company's ability to supply pharmaceutical products to European markets, which can translate into future export revenue. However, without details on the facility, product scope, or revenue impact, the immediate stock price effect is likely to be modest.